FITC

产品说明书

Print
Chemical Structure| 3326-32-7 同义名 : 异硫氰酸荧光素(异构体I) ;Fluorescein 5-isothiocyanate;5-FITC;5-Isothiocyanatofluorescein;FITC isomer I;Fluorescein isothiocyanate isomer I
CAS号 : 3326-32-7
货号 : A770877
分子式 : C21H11NO5S
纯度 : 98% (HPLC)
分子量 : 389.381
MDL号 : MFCD00005063
存储条件：

Pure form Keep in dark place,Inert atmosphere,2-8°C

In solvent -20°C:3-6个月-80°C:12个月
溶解度 :

DMSO: 50 mg/mL(128.41 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO
动物实验配方：
生物活性
描述 FITC is a derivative of fluorescein used in wide-ranging applications including flow cytometry. FITC has excitation and emission spectrum peak wavelengths of approximately 495 nm/519 nm.
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03152149 Chronic Obstructive Pulmonary ... 展开 >>Disease 收起 << Phase 4 Recruiting December 2018 United Kingdom ... 展开 >> NHS Tayside Recruiting Dundee, United Kingdom, DD1 9SY Contact: James Chalmers, MBChB, MRCP    01382 386131    j.chalmers@dundee.ac.uk    NHS Greater Glasgow and Clyde Recruiting Glasgow, United Kingdom Contact: John Haughney          Northumbria Healthcare NHS Foundation Trust Recruiting North Shields, United Kingdom, NE29 8NH Contact: Stephen Bourke          Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH Contact: Dominick Shaw 收起 <<
NCT02903771 Ovarian Neoplasms ... 展开 >> Fallopian Tube Neoplasms Peritoneal Neoplasms 收起 << Phase 1 Recruiting December 2019 United States, Oklahoma ... 展开 >> Peggy and Charles Stephenson Cancer Center, OU Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Principal Investigator: Dr K Moore          United States, Rhode Island Lifespan Cancer Institute, Rhode Island Hospital Not yet recruiting Providence, Rhode Island, United States, 02903 Principal Investigator: Don Dizon, MD FACP          United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 Principal Investigator: Minal Barve, MD          Australia, New South Wales Westmead Adults Hospital Recruiting Westmead, New South Wales, Australia, 2145 Principal Investigator: Prof Paul Harnett, MBBS FRACP PhD          Australia, Queensland ICON Cancer Care Recruiting South Brisbane, Queensland, Australia, 4101 Principal Investigator: Jermaine (Jim) Coward, MBBS MRCP FRACP PhD          Australia, South Australia Flinders Medical Centre Recruiting Adelaide, South Australia, Australia Principal Investigator: Dr G Kichenadasse 收起 <<
NCT03034850 - Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.84mL

2.57mL

1.28mL

25.68mL

5.14mL

2.57mL